POCT is considered together of the foremost reasonable technologies of world medical specialty market, and development in POCT technologies over amount of your time has been meted out through innovations in smart and transportable bio-sensor, computing, and knowledge and communication technologies. According to market consultants the factors helping the expansion of POC medical specialty market are many government initiatives have power-assisted within the development of innovative outpatient care models, to reduce hospital stays and quickly increasing demand for home health care globally.
How Big is The Global Point-of-Care Testing (POCT) Market?
The Global Point-of-Care Testing (POCT) Market is expected to be around US$ 58 Billion by 2028 at a CAGR of 9% in the given forecast period.
The major driving factors of Global Point-of-Care Testing (POCT) Market are as follows:
The restraining factors of Global Point-of-Care Testing (POCT) Market are as follows:
The Global Point-of-Care Testing (POCT) Market is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others. Based on End user it covers Clinics, Home, Laboratories, Assisted living healthcare facilities and Hospitals. Global Point-of-Care Testing (POCT) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Point-of-Care Testing (POCT) Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Point-of-Care Testing (POCT) Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Global Point-of-Care Testing (POCT) Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Acrongenomics, Inc., Siemens AG, Abbott Laboratories, Inc. Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc. AccuBioTech Co., Ltd., ACON Laboratories, Inc., bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc. Alpha Scientific, Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Point-of-Care Testing (POCT) Market has been segmented as below:
By Product Type:
By End-User Type:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Point-of-Care Testing (POCT) Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Point-of-Care Testing (POCT) Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Enzyme Immunoassay (EIA) Reagents and Devices Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation Methodology
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Research Design
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: Market Growth Rate, By Product (2016–2021)
4.3 Geographic Analysis: Market Size, By Mode of Prescription, 2016 vs 2021
4.4 Market, By End User and Region, 2016 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.3.1.2 Increasing Incidence of Lifestyle Diseases
5.3.1.3 Rising Usage of Home-Based POC Devices
5.3.1.4 Growing Government Support
5.3.1.5 Private Investments and Venture Capital Activities
5.3.1.6 Technological Advancements and New Product Launches
5.3.1.7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
5.3.1.8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
5.3.1.9 Rising Number of Clia-Waived POC Tests
5.3.2 Restraints
5.3.2.1 Product Recalls
5.3.2.2 Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints Hampering Profits
5.3.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
5.3.3 Opportunities
5.3.3.1 Emerging Markets (India, China, and Brazil) to Pave New Growth Avenues
5.3.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
5.3.3.3 Increasing Number of Conferences and Events
5.3.3.4 Miniaturization of POC Testing Devices
5.3.3.5 POC Tests With Multiplexing Capabilities
5.3.4 Challenges
5.3.4.1 Lack of Alignment With Definitive Central Lab Methods
5.3.4.2 Disadvantages of POC Testing Over Central Lab Methods
5.3.4.3 Inadequate Knowledge About Use of POC Devices in Professional Settings
5.3.4.4 Reluctance Towards Changing Existing Treatment Practices
5.3.5 Burning Issues
5.3.5.1 Unfavorable Reimbursement Limiting the Adoption of POC Tests
5.3.5.2 High Cost of Devices—A Prime Concern
5.3.5.3 Negative Public Perception Related to POC Tests
6 Industry Trends
6.1 Introduction
6.2 Industry Trends
6.2.1 Standardization of POC Testing Devices
6.2.2 Acquisition of Small Players
6.2.3 Growing Focus on Microfluidics-Based POC Devices
6.2.3.1 Microfluidics-Based Loc Devices Will Bring Laboratory Testing to the Patient’s Fingertips
6.2.3.2 Evolution of Paper-Based Microfluidic POC Diagnostic Devices
6.3 Pricing and Cost Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
6.5 Strategic Benchmarking
6.5.1 Technology Integration & New Product Launches
6.5.2 Incorporation of Wireless Technology in POC Devices
7 Point-Of-Care Diagnostics Market, By Product
7.1 Introduction
7.2 Glucose Monitoring Kits
7.3 Cardiometabolic Monitoring Kits
7.3.1 Cardiac Markers
7.3.2 Blood Gas/Electrolytes Testing Kits
7.3.3 HBA1C Testing Kits
7.3.4 LIPID Testing Kits
7.4 Infectious Disease Testing Kits
7.4.1 Influenza Testing Kits
7.4.2 HIV Testing Kits
7.4.3 Hepatitis C Testing Kits
7.4.4 Sexually Transmitted Diseases (STDs) Testing Kits
7.4.5 Tropical Diseases Testing Kits
7.4.6 Healthcare-Associated Infection Testing Kits
7.4.7 Respiratory Infections Testing Kits
7.4.8 Other Infectious Disease Testing Kits
7.5 Coagulation Monitoring Kits
7.5.1 PT/INR Testing Kits
7.5.2 Activated Clotting Time (ACT/APTT) Testing Kits
7.6 Pregnancy and Fertility Testing Kits
7.6.1 Pregnancy Testing Kits
7.6.2 Fertility Testing Kits
7.7 Tumor/Cancer Markers
7.8 Urinalysis Testing Kits
7.9 Cholesterol Test Strips
7.10 Hematology Testing Kits
7.11 Drugs-Of-Abuse Testing Kits
7.12 Fecal Occult Testing Kits
7.13 Other POC Testing Kits
8 Point-Of-Care Diagnostics Market, By Prescription Mode
8.1 Introduction
8.2 Prescription-Based Testing Kits
8.3 OTC Testing Kits Market
9 Point-Of-Care Diagnostics Market, By End User
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Hospitals/Critical Care Settings
9.2.2 Outpatient Healthcare Settings
9.2.3 Ambulatory Care Settings
9.3 Research Laboratories
9.4 Home Care
9.5 Others
10 Point-Of-Care Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Growing Prevalence of Lifestyle Diseases and Rising Geriatric Population
10.2.1.2 Increasing Government and Venture Capital Funding
10.2.1.3 Growing Number of Product Approvals Using Clia Waiver
10.2.1.4 Nih Support for the Development of POC Testing Devices
10.2.1.5 Slow Inflow of Multi-Analyte POC Devices
10.2.2 Canada
10.2.2.1 Expanding Patient Population Base
10.2.2.2 Increasing Focus of Players on the Canadian Market
10.2.2.3 Increasing Government Initiatives
10.2.2.4 Lack of Reimbursement and Awareness
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Number of Conferences
10.3.1.2 Ongoing Development of Novel Products
10.3.1.3 Rising Incidence of Diabetes and Cancer in Germany
10.3.1.4 Low Reimbursement Affecting Market Growth in the Country
10.3.2 France
10.3.2.1 Increasing Reimbursement for Point-Of-Care Tests
10.3.2.2 High Prevalence of Diabetes in France
10.3.3 U.K.
10.3.3.1 Growing Number of New Product Launches
10.3.3.2 Increasing Government Support for POCt Devices
10.3.3.3 Budget Constraints Hampering Market Growth
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Growing Initiatives By Market Players
10.4.1.2 Increasing Demand for Rapid Flu Tests in Japan
10.4.1.3 Centralized Healthcare Delivery System
10.4.2 China
10.4.2.1 Increasing Partnerships and Joint Ventures Fueling Market Growth
10.4.2.2 Increasing Support From Government and Private Companies
10.4.2.3 Poor Reimbursement and Time-Consuming Product Registration Procedure
10.4.3 India
10.4.3.1 Increasing Prevalence of Target Diseases
10.4.3.2 Growing Government Initiatives
10.4.3.3 Conferences
10.4.3.4 Lack of Reimbursement and Insurance Coverage Hampering Market Growth
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)
10.5.1 Increasing Patient Population in Africa
10.5.2 Huge Patient Base for Respiratory Diseases
10.5.3 Growing Initiatives By Market Players
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches,Product Enhancements, and Product Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Product Showcase and Product Recall
11.3.4 Acquisitions
11.3.5 Other Strategies
12 Company Profiles
12.1 Introduction
12.2 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.3 Abbott Laboratories, Inc.
12.4 Siemens AG
12.5 Alere Inc.
12.6 Johnson & Johnson
12.7 Instrumentation Laboratory (A Werfen Company)
12.8 Nova Biomedical
12.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.10 Becton, Dickinson and Company
12.11 PTs Diagnostics
The Global Point-of-Care Testing (POCT) Market has been segmented as below:
By Product Type:
By End-User Type:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
